This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation
Chiyu Ge, Junli Zhang, Feng Feng
TL;DR
This retraction notice informs that a 2019 study on how salidroside boosts imatinib's effect against leukemia is being retracted.
Contribution
The paper formally retracts a prior study, indicating issues with its validity or integrity.
Findings
The original study's claims about salidroside and imatinib's combined effect are no longer considered valid.
The retraction highlights the importance of verifying scientific results before publication.
Abstract
Retraction of ‘Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation’ by Chiyu Ge et al., RSC Adv., 2019, 9, 25022–25033, https://doi.org/10.1039/C9RA01683J.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutophagy in Disease and Therapy · Medicinal Plants and Bioactive Compounds · Lipid metabolism and disorders